CD226 and Miyoshi myopathy: The mechanism underlying the enhanced tumor cell killing may involve the increased expression of MICA, MICB, PVR, and Nectin-2 proteins on MM cells and the ligands of the activating receptors, NKG2D and DNAM-1.